Search research articles
Contact Us
Filters
Showing results (91-100 of 204) with videos related to
Page
of 21
Sort By:
Familial Cancer
|
May 15, 2022
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
Vera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, et al.
Journal of Genetic Counseling
|
April 29, 2026
Digital genetic counseling services for cascade cardiogenetic testing
Marlies N van Lingen, Sietske A L van Till, Noor A A Giesbertz, et al.
Hereditary Cancer in Clinical Practice
|
September 8, 2022
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing
Kyra Bokkers, Eveline M A Bleiker, Jacob P Hoogendam, et al.
Revista Espanola De Salud Publica
|
September 10, 1999
[Extracurricular activities of adolescents useful for smoking prevention programs. OCTOPUS team]
M L López González, T López, A Comas Fuentes, et al.
Familial Cancer
|
May 29, 2024
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow
Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, et al.
Plos One
|
February 15, 2013
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers
Petra van der Groep, Paul J van Diest, Yvonne H C M Smolders, et al.
Gynecologic Oncology
|
August 28, 2022
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective
K Bokkers, G W J Frederix, M E Velthuizen, et al.
Familial Cancer
|
February 3, 2016
Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study
J E Baars, A M van Dulmen, M E Velthuizen, et al.
Familial Cancer
|
May 9, 2024
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives
Michiel Vlaming, Margreet G E M Ausems, Gina Schijven, et al.
Plos One
|
May 23, 2015
Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter study
J S de Groot, C B Moelans, S G Elias, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 204) with videos related to
Sort By:
Page
of 21
Familial Cancer
|
May 15, 2022
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups
Vera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, et al.
Journal of Genetic Counseling
|
April 29, 2026
Digital genetic counseling services for cascade cardiogenetic testing
Marlies N van Lingen, Sietske A L van Till, Noor A A Giesbertz, et al.
Hereditary Cancer in Clinical Practice
|
September 8, 2022
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing
Kyra Bokkers, Eveline M A Bleiker, Jacob P Hoogendam, et al.
Revista Espanola De Salud Publica
|
September 10, 1999
[Extracurricular activities of adolescents useful for smoking prevention programs. OCTOPUS team]
M L López González, T López, A Comas Fuentes, et al.
Familial Cancer
|
May 29, 2024
Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow
Vera M Witjes, Dorien M A Hermkens, Julie E M Swillens, et al.
Plos One
|
February 15, 2013
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers
Petra van der Groep, Paul J van Diest, Yvonne H C M Smolders, et al.
Gynecologic Oncology
|
August 28, 2022
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective
K Bokkers, G W J Frederix, M E Velthuizen, et al.
Familial Cancer
|
February 3, 2016
Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study
J E Baars, A M van Dulmen, M E Velthuizen, et al.
Familial Cancer
|
May 9, 2024
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives
Michiel Vlaming, Margreet G E M Ausems, Gina Schijven, et al.
Plos One
|
May 23, 2015
Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter study
J S de Groot, C B Moelans, S G Elias, et al.
Page
of 21